Envetec's unique technology enables clinical laboratories to create clean change by eliminating the existing harmful treatment of biohazardous laboratory waste

Oculer is a leader in industrial microbiology rapid testing for the food, beverage and pharmaceutical industries. Oculer has successfully developed rapid, high-throughput, fully automated assays for the detection of bacteria and yeast & mould, enabling food and beverage manufacturers to detect microbial contamination in their products and manufacturing processes faster and more precisely than industry alternatives.

Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Our current lead drug candidate, FT218, is an investigational formulation of sodium oxybate leveraging our proprietary drug delivery technology and designed to be taken once at bedtime for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy.

Technopath Clinical Diagnostics is a global leader in the development and manufacture of quality controls and software which enhance the reporting of patient test results by clinical laboratories. Technopath was acquired by LGC Group in January 2021.

leon-nanodrugs GmbH, headquartered in Munich, is a nanotechnology-based drug development company focused on reformulations and reinventions of drugs on a contract or co-development.

Corporate development activities for Northwell Holdings, the for-profit business unit of Northwell Health.

ValitaCell’s mission is to accelerate the pace and reduce the cost of manufacturing innovative medicines. Our team is focused on creating analytical technologies that empower scientists with rich cell data and insights earlier in the drug discovery and development process.

Elan Drug Technologies (EDT) is an established, profitable and growing drug delivery and specialty pharmaceutical business unit of Elan Corporation plc.

Specialty pharmaceutical product development company

NASDAQ listed biotechnology company focused on immuno-oncology.